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Background: Coronary-artery-bypass-grafting (CABG) with conventional extracorporeal circulation (CECC) is
associated with adverse effects such as systemic inflammatory response leading to a decrease in systemic vascular
resistance and hemodynamic instability. Modern "less invasive" procedures have been established recently which
potentially avoid negative side effects of CECC. The aim of this study was to compare perioperative outcome
following coronary revascularization using either a minimized extracorporeal circuit (Mini-HLM) or off-pump
technique (OPCAB).
Methods: In this prospective ethics-approved trial, 120 patients referred for CABG were randomly assigned either to
off-pump coronary artery bypass (OPCAB) or to a Mini-HLM procedure. Patient demographics, preoperative
characteristics and extensive postoperative outcome were analyzed for both groups. Hemodynamic data were
measured at seven time points perioperatively.
Results: Operation-time was longer in the Mini-HLM group (178,3 ± 32,9 min) compared to OPCAB (133,2 ±
32,7 min, p < 0,001) with higher graft numbers in Mini-HLM group (3,11 ± 0,7 vs. 1,78 ± 0,7, p < 0.001). There were
no significant differences in perioperative hemodynamic criteria, catecholaminergic support, hospital (p = 0,534) and
intensive care unit stay (p = 0,880), ventilation time (p = 0,113), blood loss (p = 0,570), transfusion requirements,
postoperative atrial fibrillation rate (p = 0,706) and neurocognitive disturbance (p = 0,297). No deaths and no
myocardial infarctions were observed.
Conclusions: Coronary revascularisation with Mini-HLM represents a suitable and "less invasive" procedure which
achieves all benefits of OPCAB but may allow for less demanding revascularisation than OPCAB in special patients with
complex coronary anatomy and can therefore be used both on a routine basis and in all "conversion" cases of OPCAB.
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Coronary artery bypass grafting (CABG) using conventional
cardiopulmonary bypass (CCPB) was first introduced into
clinical practice in 1950 [1] and is currently the most com-
mon procedure in surgical treatment of multivessel coron-
ary artery disease (CAD) [2-5]. Although several technical
as well as surgical and anesthesiological improvements have
been conducted [6], the traditional approach requires the
use of extracorporeal circulation (ECC), total aortic cross-
clamping and myocardial ischemia. In the last two decades,
there has been significant interest in the development of
alternative surgical treatment procedures in order to
minimize the adverse effects associated with the use of
CCPB [7,8]. The relevance of this trend has received con-
siderable attention mainly with regard to minimizing the
contact of blood with foreign surfaces [9] and thus redu-
cing or completely avoiding the cardiopulmonary bypass.
As a result, there are several less-invasive surgical options
for coronary revascularization: either with the use of a
minimized extracorporeal circuit (Mini-HLM), in off-
pump technique via median sternotomy (OPCAB) or via
anterolateral mini-thoracotomy in terms of the MIDCAB
(minimally invasive direct coronary artery bypass) ap-
proach to the culprit LAD lesion with or without hybrid
PTCA of additional coronary lesions [10,11]. Currently,
advantages and disadvantages of different approaches are
intensively discussed. Consequently, many recent studies
have focused on the benefits and drawbacks of different
techniques. In comparison to other methods usually only
one coronary vessel can be revascularized using the
MIDCAB technique [12]. Even though the early control
angiography results confirmed a very good global
MIDCAB patency rate (97.8%) and appear to be even
superior to the corresponding results of conventional
bypass surgery [11,13], the application of MIDCAB in
multivessel disease has been a subject of controversy re-
garding the completeness of myocardial revasculariza-
tion. The objective of this paper is to critically examine
both two alternative procedures for elective treatment
of multivessel CAD in less invasive coronary artery by-
pass surgery: OPCAB and Mini-HLM. Our preliminary
investigation was conducted with special attention to
the evaluation of potential differences between both
CABG procedures with regard to perioperative outcome
including invasive serial hemodynamic characteristics.
Methods
In this prospective randomized clinical trial, 120 patients
referred for isolated elective CABG between December
2008 and July 2011 were enrolled in the study and pre-
operatively randomized either to OPCAB (n = 44) or
Mini-HLM (n = 76) group. The study was performed with
the approval of the ethics committee of the medical faculty
of the University of Cologne and was in compliance withthe Helsinki declaration. For randomization, we initially
decided to use the patient chart number with even last
digits for the OPCAP- and uneven last digits for the mini-
HLM cohort. Unfortunately, this method resulted in an
asymmetric distribution of patients rather than a 1:1 ratio;
however, in order to avoid a change in the randomization
procedure in the ongoing study we continued with this
method. After assessment of each coronary angiographic
examination by the operating surgeon with special em-
phasis on the general acceptability all patients were in-
formed about the study. The appropriate written informed
consent was obtained from each patient of this clinical trial,
and all perioperative data were collected electronically.
Included were patients with coronary artery disease and in-
dication for CABG. In order to guarantee the comparability
of the two study groups, patients with the following condi-
tions were excluded from the trial: significantly impaired
left ventricular pump function (ejection fraction <20%), pre-
operative catecholaminergic support, hemodynamic in-
stability, mechanical circulatory assistance as well as urgent
and emergent cases.
The primary end point of our clinical trial was the in-
hospital mortality, secondary end points were intra- and
postoperative characteristics with the emphasis on inva-
sive hemodynamic assessment using a pulmonary artery
catheter (PAC) as described below.Surgical procedure and perioperative care
All operations were performed by only three senior cardiac
surgeons with high experience in OPCAB revascularization
in cooperation with experienced anesthesiologists and per-
fusionists in our department. The surgical access was
performed via median sternotomy. The left (LIMA) and -
when applicable - right internal mammary artery (RIMA)
were harvested together with veins and surrounding tissue
as a pedicle graft in both groups. Additional graft material
(saphenous vein) was harvested using minimal invasive
technique. Body temperature was kept as normal as pos-
sible, either by the heat exchange system of the Mini-HLM
or by specific warming blankets of different manufacturers
in the OPCAB group. No patient was discharged from OR
with a temperature below 36.0°C. In all cases of CABG
using Mini-HLM several doses of Calafiore warm blood
cardioplegia were given in an antegrade fashion through
the aortic root after establishment of cardiopulmonary
bypass with an arterial cannula in the ascending aorta and
a two-stage venous cannula introduced through the
right atrium. In OPCAB, a Medtronic Urchin Evo Heart
Positioner (Medtronic, Inc., Minneapolis, USA) was used
to allow for effective positioning of the heart and enhanced
visualization of the anastomotic sites during beating heart
surgery. A Medtronic Octopus System was utilized to
enhance visibility at the anastomotic site.




Priming volume (static) 135 mL
Membrane surface area approx. 1,5 m2
Fiber material microporous polypropylene
Bubble trap
Type CAPIOXWBT15X
Priming volume 150 mL
Filter pore area 60%
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Priming volume 48 mL
Surface area 0,02 m2
Total component priming volume 503 mL
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transferred to the cardiac ICU. Perioperative care of the
patients was performed according to standard protocols of
our department.
Technical characteristics of Mini-HLM
The ROCsafe Mini-HLM is a closed loop minimized cir-
culatory circuit that consists of a centrifugal pump head
(Sarns™ 164275X, Terumo Cardiovascular Systems, Ann
Arbor, MI, USA), a microporous polypropylene fiber oxy-
genator (CAPIOXW RX15E, Terumo Corporation, Tokyo,
Japan) including a heat exchange system and a 40-μm
polyester arterial blood filter (AL8X, Pall, East Hills, NY,
USA). The low prime oxygenator of ROCsafe Mini-HLM
facilitates high oxygen transfer (oxygen transfer capacity:
337 mL/min at 5 L/min blood flow) in combination
with low priming volume (oxygenator priming volume:
135 mL). Additionally this model provides an air removal
function on the venous line allowing an effective air elim-
ination before it enters the centrifugal pump. In case of air
in the venous line, the ultrasound-controlled bubble de-
tector leads to a speed reduction of the centrifugal pump,
closure of the electronic venous line occluder (Terumo
Corporation, Tokyo, Japan) and removing of trapped air
from the bubble trap (CAPIOXW BT15X, Terumo) via
vacuum suction device. Residual micro air can be elimi-
nated by the oxygenator and arterial filter. This process
takes a few seconds before circulation can be resumed.
The total component priming volume is approximately
500 ml (Table 1).
Assessment of patient’s hemodynamics and clinical
parameters
Measurement of perioperative hemodynamic parameters
was routinely performed using Swan-Ganz-CCOmbo PAC
(Edwards Lifesciences), which was inserted in Seldinger
technique during the induction of anesthesia and removed
directly after the last measurement 24 hours postopera-
tively in the ICU. Systemic vascular resistance (SVR),
pulmonary vascular resistance (PVR), cardiac output
(CO), cardiac index (CI), pulmonary capillary wedge pres-
sure (PCWP), central-venous pressure (CVP), mixed ven-
ous oxygen saturation (svO2), arterial systolic (ASP),
diastolic (ADP) and mean pressures (AMP) as well as pul-
monary arterial systolic (PASP), diastolic (PADP) and
mean pressures (PAMP) were recorded at seven time
points perioperatively: skin cut ("OP-0"), post Mini-HLM
/OPCAB-stabilizer ("OP-1"), skin closure ("OP-2"), one
hour ("ICU-1"), six hours ("ICU-2"), 12 hours ("ICU-3")
and 24 hours after surgery ("ICU-4") respectively. These
data were collected automatically using clinical pressure
monitoring equipment in combination with the Vigilance
Monitor without performing bolus thermodilution mea-
surements. SvO2 was monitored by fiberoptic reflectancespectrophotometry available in the PAC model 744HF75
that was used in our study. Additionally this model pro-
vides an antimicrobial heparin coating in order to minimize
viable microbe count of the catheter surface during place-
ment as well as to guarantee a long-term protection against
thrombogenesis [14].
Perioperative clinical characteristics were assessed by
evaluating the medical charts of the patients during their
hospital stay and after their discharge. The data of the
perioperative hemodynamic measurements were directly
documented at the appropriate time points.
Statistical analysis
Statistical analysis was performed by SPSS 19.0 (SPSS Inc.,
Chicago, IL, USA). All continuous variables are expressed
as mean ± standard deviation (SD). Categorical data are
expressed as frequencies and percentages. Statistical ana-
lysis of metric and dichotomous parameters was carried
out using T test and Chi-square test respectively. A p < 0,05
was considered statistically significant.
Results
The preoperative data were comparable between patients
of both groups of the study. Table 2 represents basic
Table 2 Patient´s demographics and perioperative data
Mini-HLM OPCAB Total p-value
Age (yrs) 65,8 ± 11,2 65,2 ± 10,4 65,6 ± 10,8 0,79
Female 9 (12,2%) 13 (28,3%) 22 (18,3%) 0,032
Height (cm) 173,5 ± 7,8 172,3 ± 8,2 173 ± 7,9 0,448
Weight (kg) 84,5 ± 13 82,8 ± 13,6 83,9 ± 13,1 0,506
Euroscore 3,2 ± 2,3 3,2 ± 2,3 3,2 ± 2,3 0,938
Vessel disease 2,7 ± 0,5 2,13 ± 0,9 2,1 ± 0,9 0,65
Preoperative creatinine (mg/dl) 0,9 ± 0,2 0,9 ± 0,3 0,9 ± 0,2 0,879
Preoperative haemoglobin (g/dl) 12,6 ± 1,7 12,4 ± 1,7 12,5 ± 1,7 0,557
Preoperative CK (U/l) 75,1 ± 59,2 79,5 ± 46,8 76,8 ± 54,6 0,675
Preoperative CK-MB (U/l) 9,5 ± 4,1 9,9 ± 5,2 9,7 ± 4,6 0,546
Preoperative Troponin T (ug/l) 0,02 ± 0,06 0,03 ± 0,1 0,02 ± 0,08 0,62
Preoperative haematocrit (%) 36,8 ± 6,2 36,3 ± 4,5 36,6 ± 5,6 0,658
Preoperative EF (%) 61,9 ± 14,7 57,8 ± 15,3 60,7 ± 14,9 0,271
Preoperative LVEDP (mmHg) 15,2 ± 7,7 13,6 ± 10,8 14,6 ± 8,8 0,498
Diabetes mellitus 13 (17,6%) 10 (21,7%) 23 (19,2%) 0,636
Arterial hypertonia 58 (78,4%) 32 (69,6%) 90 (75,0%) 0,298
Hyperlipoproteinemia 57 (77,0%) 32 (69,6%) 89 (74,2%) 0,396
Previous stent implantation 14 (18,9%) 12 (26,1%) 26 (21,7%) 0,371
Previous statin therapy 63 (85,1%) 36 (78,3%) 99 (82,5%) 0,38
Preoperative atrial fibrillation 4 (5,4%) 0 4 (3,3%) 0,297
History of acute myocardial infarction 29 (39,2%) 12 (26,1%) 41 (34,2%) 0,168
Prior bypass surgery 0 0 0
Previous lysis of intravascular thrombus 0 0 0
Preoperative hemodynamic instability 0 0 0
CK creatine kinase, CK-MB creatine kinase isoenzyme, EF ejection fraction, LVEDP left ventricular end-diastolic pressure.
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ical characteristics of all patients undergoing either
OPCAB or CABG using Mini-HLM. The mean age
of the population was 65,6 ± 10,8 years within a range of
40–89 years. 18,3% (n = 22) of patients were female. A his-
tory of hypertension, hyperlipidemia, diabetes, previous
stent implantation, statin therapy, atrial fibrillation, myo-
cardial infarction as well as logisticEuroscore and pre-
operatively assessed heart pump function were equally
distributed between groups. There were no considerable
discrepancies concerning serological parameters (creatine
kinase (CK), CK-MB, Troponin T, hemoglobin, creatinine
and hematocrit) as well.
Every single patient in both the Mini-HLM and the
OPCAB group received a LIMA-graft to the left anterior
descending artery (LAD) as a significant LAD-stenosis/
occlusion was present in all operated patients. The usage of
bilateral internal mammary artery was comparable between
the two groups (Table 3). In the OPCAB group, a signifi-
cantly lower mean number of grafts was performed as
compared to the Mini-HLM group (1,78 ± 0,7 vs. 3,11 ± 0,7,
p < 0.001) although anatomically complete revascularizationwas intended in all patients of both treatment cohorts. By
surgical expertise of the operating surgeons, inappropri-
ate incomplete revascularization was precluded in each
patient. The procedure time was significantly longer in
the Mini-HLM group (178,3 ± 32,9 min) compared to
the OPCAB group (133,2 ± 32,7 min, p < 0,001). How-
ever, there were no significant differences in periopera-
tive hemodynamics (Figure 1a-c), inotropic support,
duration of hospital (p = 0,534) and intensive care unit
stay (p = 0,88), ventilation time (p = 0,113), blood loss
(p = 0,57), transfusion requirements, postoperative atrial
fibrillation rate (p = 0,706) and neurocognitive disturb-
ance (p = 0,297). There were no deaths and no myocar-
dial infarctions observed in either group. All cases were
performed as intended with no need for conversion to
CCPB (Tables 3 and 4).
Serial assessment of patient’s hemodynamics did not
result in statistically significant differences in most in-
stances between the two groups (Figure 1, a-c). Despite
the existence of minor significant differences, the corre-
sponding values were within the normal range in both
groups, indicating no major clinical relevance.
Table 3 Intraoperative data




3,11 ± 0,7 1,78 ± 0,7 2,6 ± 0,97 <0,001
Operating
time (min)
178,3 ± 32,9 133,2 ± 32,7 160,9 <0,001
LIMA and
RIMA usage
19 (25,7%) 9 (19,6%) 28 (23,3%) 0,51
Transfusion
of PRBC
0,4 ± 0,9 0,4 ± 1,0 0,42 ± 1,0 0,97
Transfusion
of FFP
0,4 ± 1,3 0,1 ± 0,5 0,3 ± 1,1 0,16
Transfusion
of platelets










FFP fresh frozen plasma, LIMA left internal mammary artery, PRBC packed red
blood cells, RIMA right internal mammary artery.
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CABG is the treatment of choice in patients with three-
vessel CAD as recommended by recent Guidelines [15].
A considerable number of reports have been published
on CABG using ECC and proved that it is a safe and
effective treatment of multivessel CAD. However, the
standard approach via median sternotomy with the use
of cardiopulmonary bypass (CPB) and aortic cross-
clamping is associated with certain negative side effects
such as systemic inflammatory response syndrome
(SIRS) which leads to potentially increased mortality and
morbidity [2,10,16-18].
To avoid these adverse effects, alternative approaches
such as OPCAB, MIDCAB and interdisciplinary hybrid
procedures have been introduced into clinical practice.
However, these approaches are sometimes technically de-
manding and therefore do not always represent the best
available technique in specific patients. Particularly off-
pump procedures require sufficient exposition of target
vessels which can be very demanding particularly when
marginal branches need to be revascularized which may
result in severe hemodynamic instability due to cardiac
displacement. Furthermore, diffuse CAD with severe calci-
fied target vessels may not always be suitable for revascu-
larization during beating heart surgery. In these instances,
the utilization of minimized extracorporeal circuits may
offer benefits for these patients as these Mini-HLM
systems have been proposed to avoid the potentially harm-
ful effects of CCPB. The basic idea of Mini-HLM is to
ensure adequate perfusion by a closed, extremely mini-
mized circuit based on a rotary blood pump and a high-performance membrane oxygenator with elimination of
blood-to-air contact by avoiding a venous reservoir, min-
imizing hemodilution and mechanical blood trauma and
significant reduction of contact activation by reduced
foreign surfaces [19]. Meanwhile, a clear superiority of
Mini-HLM systems could be proven when compared to
conventional CPB circuits [7,9,10,16,20].
In the present study we compared OPCAB revasculari-
zation with on-pump procedures utilizing a Mini-HLM,
and comparable excellent clinical results could be demon-
strated in both groups without any significant differences.
Particularly mortality, postoperative morbidities and com-
plication rates as well as clinical variables of the periopera-
tive period, e.g., blood loss, transfusion requirements,
ventilation- and total-hospital-times were not significantly
different between both groups. Nevertheless, this is an ex-
tremely important result with high clinical impact as the
use of CCPB has been associated with a couple of the
above-mentioned negative side effects. Based on these
concerns with CCPB, a significant amount of studies deal
with the OPCAB procedure as as a well-established and
safe minimal invasive procedure for coronary artery revas-
cularization [21,22]. This technique has been extensively
studied and was shown to reduce the incidence of post-
operative complications such as SIRS, myocardial and
cerebral dysfunction and hemodynamic instability associ-
ated with the use of CCPB [18]. Additionally the lower
cost factor and availability of mechanical stabilizers [22,23]
made this approach more appealing, even though this
method of myocardial revascularization appeared to be
technically more demanding and more complex and al-
though some authors report even higher hospital costs
with longer hospital stays after OPCAB procedures [5].
Further findings strongly support the general impression
that OPCAB represents an alternative approach for pa-
tients with increased risk of ECC on the basis of lower
mortality [23,24]. For a long time this method was the
only alternative surgical approach for patients with severe
comorbidities, who had absolute contraindications for op-
erations using ECC [25]. Among numerous other benefits,
improved perioperative outcome including reduced cate-
cholaminergic support, transfusion requirements, ventila-
tion time and lower impairment rate of the preexistent
renal insufficiency was shown in patients with at least 50%
main left coronary artery stenosis operated on in OPCAB
technique as compared to a CCPB group [26].
In our study the utilization of Mini-HLM, however,
resulted in a completely comparable low complication rate
compared to the off-pump group. Therefore, broader
introduction of minimized circulatory systems into clinical
practice has the promising potential to reduce negative side
effects of standard CPB systems. Moreover, hemodynamic
measurements in the present study did not show any sig-











































































Figure 1 Perioperative hemodynamic measurements using a pulmonary artery catheter (Edwards Lifesciences). There are no significant
differences between the two groups at most time points (p > 0,05), few differences (p < 0,05) have no clinical significance because the corresponding
values remain in the normal range. a: Pulmonary vascular resistance (PVR), y-axis in [dyne*sec/cm5]; b: Cardiac index (CI), y-axis in [l/min/m2 BSA];
c: Pulmonary capillary wedge pressure (PCWP), y-axis in [mmHg]. "OP-0", skin cut; "OP-1", post Mini-HLM/OPCAB-stabilizer; "OP-2", skin closure;
“ICU-1”: one-hour post-op; "ICU-2": six-hour post-op; "ICU-3”: 12-hour post-op; "ICU-4": 24-hour post-op.
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safe and did not lead to hemodynamic instability.
A significant finding of our study was a higher rate of
distal anastomoses in the Mini-HLM group. As an often
quoted limitation of OPCAB procedures, completecoronary revascularization might not be achievable in all
patients by off-pump techniques owing to the complex
anatomy of coronary lesions and the possibility of
hemodynamic instability while the beating heart is manipu-
lated. In a study with 2203 patients undergoing off-pump
Table 4 Postoperative data
Mini-HLM OPCAB Total p-Wert
Ventilation time (min) 15,4 ± 7,9 13,4 ± 3,8 14,6 ± 6,7 0,113
Total chest tube drainage (ml) 1266 ± 707 1039 ± 449 1178 ± 628 0,057
ICU stay (d) 2,6 ± 1,3 2,6 ± 2,3 2,6 ± 1,7 0,880
In-hospital stay (d) 12,5 ± 7,1 11,5 ± 9,3 12,1 ± 8,0 0,534
Transfusion of PRBC 1,4 ± 1,9 0,8 ± 1,2 1,2 ± 1,7 0,090
Transfusion of FFP 0,74 ± 1,9 0,6 ± 1,3 0,7 ± 1,7 0,651
Transfusion of platetets 0,3 ± 0,6 0,1 ± 0,4 0,2 ± 0,5 0,270
Catecholaminergic support
Norepinephrine 3,7 ± 3,9 12,3 ± 58,5 7,0 ± 36,3 0,218
Epinephrine 0 1,3 ± 7,9 0,5 ± 4,9 0,161
Dobutamine 288 ± 327 195 ± 370 253 ± 346 0,161
Milrinone 0 0,8 ± 5,3 0,3 ± 3,3 0,210
Symptomatic transitory psychotic syndrome 4 (5,4%) 0 4 (3,3%) 0,297
Cerebral vascular accident 2 (2,7%) 0 2 (1,7%) 0,523
Atrial fibrillation 30 (41,7%) 21 (45,7%) 51 (43,2%) 0,706
Use of class III antiarrhythmics 15 (20,5%) 7 (15,2%) 22 (18,5%) 0,629
Readmission to the ICU 3 (4,1%) 1 (2,2%) 4 (3,3%) 1,0
Reintubation 1 (1,4%) 1 (2,2%) 2 (1,7%) 1,0
Sepsis 1 (1,4%) 1 (2,2%) 2 (1,7%) 1,0
Creatinine 24–48 hours after surgery (mg/dl) 1,15 ± 0,38 1,06 ± 0,37 1,12 ± 0,38 0,202
CVVH 0 0 0
Deep sternal wound infection 6 (8,1%) 2 (4,3%) 8 (6,7%) 0,709
Sternal instability 3 (4,1%) 1 (2,2%) 4 (3,3%) 1,0
Hospital mortality 0 0 0
Perioperative myocardial infarction 0 0 0
CPR 0 0 0
CPR cardiopulmonary resuscitation, CVVH continuous veno-venous hemodialysis, FFP fresh frozen plasma, ICU intensive care unit, PRBC packed red blood cells.
Wittwer et al. Journal of Cardiothoracic Surgery 2013, 8:75 Page 7 of 10
http://www.cardiothoracicsurgery.org/content/8/1/75and on-pump procedures, Shroyer et al. [18] have reported
a significantly lower revascularization rate (2,9 ± 0,9 and
3,0 ± 1,0, respectively; p = 0,002) as well as a higher propor-
tion of patients with fewer grafts than originally planned in
the off-pump group than in the on-pump group (17.8% vs.
11.1%, P < 0.01). The overall rate of graft patency was lower
in the off-pump group than in the on-pump group (82.6%
vs. 87.8%, P < 0.01). However, the required level of surgical
experience in OPCAB revascularization was not well deter-
mined in this ROOBY trial which is considered to be a cer-
tain drawback of that study. Nevertheless, other reports
have also shown a higher number of grafts [10,21,22] and a
lower rate of repeat revascularization [27] observed in on-
pump patients as compared to OPCAB-operated patients.
Correspondingly, in the study by Alamanni et al., OPCAB
was identified as the most significant predictor (OR 7,1,
95% CI 5,9-8,3, p < 0,001) of incomplete revascularization
[28]. Additionally, a study comparing standard CPB, mini-
mized extracorporeal circulation system (MECC) andOPCAB (10) has shown a similar revascularization rate in
the on-pump groups (3,2 ± 0,6 in the MECC group and
3,4 ± 0,7 in the CCPB group) while the revascularization
rate was significantly lower in the off-pump group (1,9 ±
0,8, p = 0,01). Similarly, in our study the overall bypass
number was lower in the OPCAB group which was mainly
due to unexpected intraoperatively observed multiple,
complex and diffuse disease or small vessels unsuitable for
surgical revascularization.
However, in the available literature there is a substan-
tial uncertainty on the definition and evaluation of the
“adequacy” of myocardial revascularization, and numer-
ous inconsistent definitions for “complete (CR)” and “in-
complete (IR)” revascularization account for some
controversies regarding mid- and long-term event-free sur-
vival [29]. Generally, a coronary revascularization is consid-
ered to be “anatomically complete” when all vessels with
clinically significant stenoses (vessel diameter > 1.5 mm;
stenosis > 50%) are treated, irrespective of the underlying
Wittwer et al. Journal of Cardiothoracic Surgery 2013, 8:75 Page 8 of 10
http://www.cardiothoracicsurgery.org/content/8/1/75myocardial function, whereas a “functionally complete” re-
vascularization refers to situations in which only lesions
supplying a viable myocardium are treated [29]. Myocardial
revascularization may therefore be both anatomically in-
complete but still functional adequate [30]. According to
Mohr et al. [31], even when CR is still the major goal of
surgical revascularization, there remain several reasons to
perform “reasonable” surgical IR, based on either preopera-
tive assessment (e.g., nondominant diseased right coronary
artery, non-vital myocardium, attempt to avoid cardiac ar-
rest for off-pump procedures in high-risk patients, limited
graft material), or more unexpected findings intraopera-
tively like in our series (i.e., small target vessels with severe
calcifications, intramyocardial coronaries, coronary injury).
Interestingly, in this important study on 8806 coronary pa-
tients with multivessel disease, IR of the circumflex or right
coronary artery - in the presence of a LIMA bypass grafted
to the LAD in all cases - was not associated with any detri-
mental effects on 1- or 3-year survival in comparison to
those patients with CR [31].
Therefore, due to these difficulties in definition and im-
pact of the “completeness of revascularization” and as
each patient of our two cohorts did receive a LIMA bypass
to the LAD, it was not the primary goal of this preliminary
study to specifically focus on complete or incomplete
revascularization rates but rather to evaluate the immedi-
ate perioperative clinical outcome including intensive care
data and hemodynamic assessment. Nevertheless, anatom-
ically complete revascularization was intended in all
Mini-HLM- and OPCAB-cases of our series, and it was
guaranteed by surgical expertise that “inappropriate
incomplete revascularization” as recently described by
Taggart [32] was avoided in each single patient. There is
no doubt, however, that the revascularization rate particu-
larly in off pump patients depends on optimal surgical
experience. On the other hand, several factors such as dif-
fuse calcification, peripheral stenosis and intramyocardial
localization of the coronary arteries may complicate the
procedure. Logically, the question always rises as to
whether a lower number of grafts in myocardial revascular-
ization with or without the use of CPB may be associated
with technical or anatomical difficulties, and thus repre-
sents a risk of incomplete myocardial revascularization
with potentially inferior outcome. Even if incomplete re-
vascularization might be unavoidable in some specific in-
stances, is was shown in a recent subgroup analysis of the
well-respected SYNTAX data [33] that in surgically treated
patients adverse events in terms of MACCE and need for
repeat revascularization are not significantly increased fol-
lowing IR as compared to CR.
Our study has revealed comparable clinical and
hemodynamic parameters between the two groups even
though the operating time was significantly longer in the
Mini-HLM group as compared to the OPCAB group(Tables 2 and 3). The reason for this result appears to be
less systemic inflammatory reaction and organ damage due
to reduced priming volume and total surface area of the cir-
cuit as well as less activation of platelets and granulocytes
compared to CCPB as previously reported [2,8,10]. Other
advantages of Mini-HLM over CCPB such as reduced he-
modilution, a decreased inflammatory response in terms of
interleukin-6 (IL-6) and C3a values as well as improved
clinical outcome were also shown in high-risk CABG pa-
tients [34]. Our general findings are also consistent with
those of Mazzei et al. [8] who found that the release of in-
flammatory markers, as well as length of intensive care unit,
hospital stay, complication rate and need for allogenic
transfusion were similar in the OPCAB and a Mini-HLM
group. Additionally, it was shown that use of modern Mini-
HLM systems as compared to CCPB is associated with
significantly reduced release of circulating endothelial cells
(CEC) who are considered to represent a novel and hyper-
sensitive marker of the severe intrinsic endothelial damage
with detachment of endothelial cells into the blood stream
caused by CCPB [35]. Recently, CEC release in Mini-HLM
procedures was found to be as low as it could be shown for
OPCAB procedures.
For the first time internationally, in this investigation
perioperative hemodynamic parameters were directly
compared in order to appraise the extent of systemic in-
flammation induced by surgical technique with may lead
to potential adverse effects such as deterioration of
hemodynamics. The results of this study did not show any
significant differences in the perioperative hemodynamics
between both groups in spite of total aortic cross-
clamping and cardiac arrest in Mini-HLM operations. Fur-
thermore, similar amounts of catecholamines were used in
both groups. A possible explanation of our favourable re-
sults may be the numerous conceptional advantages of
Mini-HLM, resulting in less perioperative systemic inflam-
mation and hemodynamics comparable to off-pump pro-
cedures. Our findings which showed that there were no
significant differences between the two groups at most
time points are also in accordance with clinical observa-
tions. The few statistical differences have no clinical sig-
nificance because the corresponding values remain within
the normal range.
This preliminary study has a number of certain limita-
tions. First, it was a single center study with a rather small
sample size. Therefore caution must be applied, as the
findings might not be transferable to larger cohorts. Fur-
thermore, clinical outcome analysis focused initially on
short-term peri- and postoperative observations, and no
long-term results are provided yet. However, ongoing ex-
perience with this continuous ethics-approved study will
result in specific intermediate- and long-term evaluations
of bypass function and persistent relief or recurrence of is-
chemic symptoms.
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Based on the results of this study, coronary revasculariza-
tion by use of the ROCsafe™ -Mini-HLM system repre-
sents a suitable and "less invasive" procedure which
achieves all benefits of OPCAB but may allow for less de-
manding revascularization than OPCAB in special patients
with complex coronary anatomy. In these patients the use
of Mini-HLM and circulatory arrest might improve the
surgical approach to the target vessels resulting in poten-
tially improved quality of anastomoses, while retaining the
benefits of off-pump procedures compared to standard
HLM such as comparable incidence of atrial fibrillation,
ventilation time, postoperative bleeding, transfusion re-
quirements, catecholaminergic support etc. as shown in
our study. This promising technique can therefore be used
both on a routine basis and especially in all patients who
are considered to be no optimal candidates for OPCAB.
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